The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Therapy of refractory/relapsed metastatic triple-negative breast cancer (TNBC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): Phase I/II clinical experience.
 
Aditya Bardia
No Relationships to Disclose
 
Linda T. Vahdat
No Relationships to Disclose
 
Jennifer Robinson Diamond
No Relationships to Disclose
 
Alexander Starodub
No Relationships to Disclose
 
Rebecca L. Moroose
No Relationships to Disclose
 
Steven J. Isakoff
Consulting or Advisory Role - BIND Biosciences; Myriad Genetics
Research Funding - Abbvie; Genentech; PharmaMar
Travel, Accommodations, Expenses - Genentech; Myriad Genetics; Myriad Genetics
 
Allyson J. Ocean
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genentech/Roche; ipsen; Lilly/ImClone; Novartis; Symphony Evolution; targovax; Vertex
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer/Onyx (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Merrimack (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); Otsuka (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie
Other Relationship - Incyte
 
Wells A. Messersmith
Consulting or Advisory Role - Morphotek; OncoMed
Research Funding - GlaxoSmithKline; Immunomedics; Millennium; OncoMed; Pfizer; Roche; Roche/Genentech
 
Sajeve Samuel Thomas
No Relationships to Disclose
 
Francois Wilhelm
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
 
William A. Wegener
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
 
Pius P Maliakal
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
 
Robert M. Sharkey
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
 
David M. Goldenberg
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
Patents, Royalties, Other Intellectual Property - Immunomedics
 
Ingrid A. Mayer
Consulting or Advisory Role - Genentech/Roche; Novartis
Research Funding - Novartis